Joshua H Levin, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Levin’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C129385 · Current
Licensed to practise in California · since 2014 · expires 2028-01-31 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$81,096
Medicare paid this office $81,096 for 512 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 191 | $20,381 | $74 |
| New patient visit (45+ min) | 88 | $10,351 | $118 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 79 | $10,257 | $114 |
| New patient visit (30+ min) | 88 | $6,494 | $74 |
| Muscle electrical test | 113 | $5,295 | $40 |
See all 16 services
| Short return visit (20+ min) | 191 | $20,381 | $74 |
| New patient visit (45+ min) | 88 | $10,351 | $118 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 79 | $10,257 | $114 |
| New patient visit (30+ min) | 88 | $6,494 | $74 |
| Muscle electrical test | 113 | $5,295 | $40 |
| Nerve test | 42 | $3,005 | $72 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $2,546 | $106 |
| Nerve test | 44 | $2,496 | $57 |
| New patient visit (45+ min) | 21 | $2,276 | $108 |
| Nerve test | 22 | $1,998 | $91 |
| New patient visit (30+ min) | 29 | $1,906 | $66 |
| Return visit (30+ min) | 18 | $1,837 | $97 |
| Short return visit (20+ min) | 23 | $1,162 | $46 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 21 | $1,001 | $46 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 45 | $655 | $15 |
| Muscle electrical test | 24 | $453 | $16 |
Who their Medicare patients are
512 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 11% · Women 52% · Also on Medicaid 17% · Health risk score 1.03. At or below the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 69% · Coronary heart disease 28% · Diabetes 23% · Cancer 19% · Chronic kidney disease 18% · Depression 17% · Atrial fibrillation 15% · Heart failure 9% · Stroke 9% · COPD 8% · Dementia 3%.
The office billed $656,403, Medicare allowed $107,374 and paid $81,096; for 1,086 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 512 | 1,086 | 75 | 1.03 | $656,403 | $81,096 |
| 2023 | 440 | 894 | 74 | 1.31 | $775,964 | $70,014 |
| 2022 | 432 | 836 | 74 | 1.15 | $762,095 | $59,948 |
| 2021 | 397 | 798 | 74 | 1.19 | $608,392 | $58,190 |
| 2020 | 329 | 655 | 73 | 1.26 | $416,693 | $40,236 |
| 2019 | 371 | 670 | 74 | 1.13 | $292,086 | $43,807 |
| 2018 | 425 | 744 | 73 | 1.26 | $336,579 | $52,393 |
| 2017 | 346 | 698 | 72 | 1.20 | $536,319 | $50,103 |
| 2016 | 347 | 680 | 71 | 1.17 | $554,584 | $53,496 |
| 2015 | 347 | 698 | 73 | 1.23 | $563,784 | $53,877 |
| 2014 | 253 | 538 | 72 | 1.08 | $356,802 | $37,434 |
| 2013 | 364 | 1,007 | 72 | 1.07 | $680,613 | $70,131 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| New patient visit (45+ min) | 73 | $7,871 | $108 |
| Short return visit (20+ min) | 103 | $7,076 | $57 |
| Short return visit (20+ min) | 90 | $6,466 | $57 |
| New patient visit (45+ min) | 48 | $5,509 | $115 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 41 | $5,180 | $115 |
| New patient visit (30+ min) | 65 | $4,353 | $67 |
| Muscle electrical test | 79 | $3,391 | $39 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 25 | $3,363 | $112 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,348 | $120 |
| Return visit (30+ min) | 25 | $2,289 | $85 |
| Nerve test | 33 | $2,241 | $68 |
| New patient visit (30+ min) | 30 | $2,196 | $73 |
| Return visit (30+ min) | 21 | $1,856 | $84 |
| Nerve test | 27 | $1,642 | $61 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,612 | $107 |
| Nerve test | 11 | $931 | $85 |
2022: 18 services
| Short return visit (20+ min) | 94 | $6,956 | $58 |
| New patient visit (45+ min) | 61 | $6,878 | $113 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 37 | $4,576 | $104 |
| New patient visit (45+ min) | 37 | $4,147 | $112 |
| Short return visit (20+ min) | 65 | $4,086 | $54 |
| New patient visit (30+ min) | 58 | $3,909 | $67 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 27 | $3,354 | $124 |
| Muscle electrical test | 72 | $3,331 | $37 |
| New patient visit (30+ min) | 45 | $2,940 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,213 | $123 |
| Nerve test | 27 | $1,612 | $60 |
| Nerve test | 17 | $1,609 | $95 |
| Return visit (30+ min) | 19 | $1,539 | $81 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,309 | $77 |
| Nerve test | 14 | $838 | $60 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $612 | $38 |
| Muscle electrical test | 18 | $325 | $17 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $65 | $5 |
2021: 17 services
| Short return visit (20+ min) | 78 | $6,060 | $58 |
| New patient visit (45+ min) | 46 | $5,562 | $121 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 43 | $5,125 | $109 |
| Muscle electrical test | 86 | $4,022 | $41 |
| Short return visit (20+ min) | 60 | $3,941 | $56 |
| New patient visit (45+ min) | 32 | $3,792 | $118 |
| New patient visit (30+ min) | 46 | $3,332 | $72 |
| New patient visit (30+ min) | 49 | $3,327 | $68 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 22 | $2,666 | $116 |
| Nerve test | 27 | $2,626 | $97 |
| Nerve test | 31 | $2,187 | $71 |
| Return visit (30+ min) | 21 | $1,934 | $84 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,472 | $98 |
| Return visit (30+ min) | 14 | $1,087 | $78 |
| Nerve test | 15 | $939 | $63 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $582 | $48 |
| Muscle electrical test | 24 | $403 | $17 |
2020: 13 services
| New patient visit (30+ min) | 91 | $5,202 | $57 |
| New patient visit (30+ min) | 76 | $5,016 | $66 |
| Short return visit (20+ min) | 63 | $4,017 | $45 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $3,932 | $119 |
| Muscle electrical test | 65 | $3,322 | $42 |
| Short return visit (20+ min) | 49 | $2,651 | $41 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,786 | $112 |
| Nerve test | 17 | $1,529 | $90 |
| Nerve test | 19 | $1,321 | $70 |
| Return visit (30+ min) | 16 | $1,142 | $71 |
| Nerve test | 18 | $1,130 | $63 |
| Return visit (30+ min) | 14 | $1,032 | $69 |
| Muscle electrical test | 12 | $213 | $18 |
2019: 16 services
| New patient visit (30+ min) | 84 | $4,731 | $56 |
| Short return visit (20+ min) | 75 | $4,181 | $44 |
| New patient visit (45+ min) | 35 | $4,002 | $114 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 34 | $3,729 | $107 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 26 | $3,266 | $121 |
| Muscle electrical test | 65 | $3,056 | $41 |
| New patient visit (30+ min) | 36 | $2,446 | $68 |
| Return visit (30+ min) | 29 | $2,027 | $68 |
| Short return visit (20+ min) | 31 | $1,791 | $46 |
| Nerve test | 25 | $1,724 | $69 |
| Return visit (30+ min) | 20 | $1,491 | $71 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,363 | $91 |
| Nerve test | 15 | $1,338 | $89 |
| Nerve test | 13 | $816 | $63 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $657 | $60 |
| Muscle electrical test | 15 | $262 | $17 |
2018: 15 services
| New patient visit (45+ min) | 65 | $6,677 | $103 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 52 | $6,452 | $115 |
| New patient visit (30+ min) | 86 | $5,268 | $61 |
| Muscle electrical test | 74 | $3,364 | $40 |
| Short return visit (20+ min) | 63 | $3,079 | $41 |
| Return visit (30+ min) | 41 | $2,875 | $64 |
| Nerve test | 35 | $2,563 | $73 |
| New patient visit (45+ min) | 19 | $2,190 | $115 |
| New patient visit (30+ min) | 30 | $1,971 | $66 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $1,853 | $98 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,707 | $90 |
| Long return visit (40+ min) | 12 | $1,197 | $100 |
| Short return visit (20+ min) | 23 | $1,106 | $44 |
| Nerve test | 12 | $1,094 | $91 |
| Muscle electrical test | 19 | $310 | $15 |
2017: 14 services
| New patient visit (45+ min) | 107 | $11,544 | $108 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 45 | $5,669 | $105 |
| New patient visit (30+ min) | 82 | $5,100 | $62 |
| Short return visit (20+ min) | 71 | $4,156 | $42 |
| Muscle electrical test | 71 | $3,386 | $41 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $3,363 | $108 |
| Return visit (30+ min) | 45 | $3,301 | $67 |
| Nerve test | 26 | $1,850 | $71 |
| Nerve test | 13 | $1,282 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $1,072 | $67 |
| Nerve test | 17 | $936 | $55 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $662 | $44 |
| Muscle electrical test | 13 | $242 | $17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $152 | $11 |
2016: 13 services
| New patient visit (45+ min) | 139 | $16,538 | $119 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 45 | $6,860 | $114 |
| Short return visit (20+ min) | 78 | $4,980 | $49 |
| New patient visit (30+ min) | 61 | $4,440 | $73 |
| Return visit (30+ min) | 41 | $3,589 | $75 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $2,718 | $101 |
| Muscle electrical test | 53 | $2,572 | $40 |
| Nerve test | 17 | $1,251 | $74 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $1,138 | $47 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $1,084 | $60 |
| Nerve test | 12 | $1,046 | $87 |
| Nerve test | 13 | $735 | $57 |
| Aspiration and/or injection of fluid from large joint | 12 | $555 | $43 |
2015: 12 services
| New patient visit (45+ min) | 162 | $17,302 | $107 |
| Short return visit (20+ min) | 79 | $4,825 | $43 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 33 | $4,226 | $111 |
| New patient visit (30+ min) | 65 | $4,188 | $64 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $3,440 | $108 |
| Muscle electrical test | 57 | $2,872 | $42 |
| Return visit (30+ min) | 33 | $2,453 | $66 |
| Nerve test | 25 | $1,804 | $72 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 17 | $1,463 | $67 |
| Nerve test | 13 | $1,282 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 11 | $911 | $65 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 17 | $852 | $47 |
2014: 12 services
| New patient visit (45+ min) | 73 | $8,325 | $114 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 28 | $3,189 | $100 |
| Muscle electrical test | 38 | $1,891 | $41 |
| New patient visit (30+ min) | 28 | $1,877 | $67 |
| Return visit (30+ min) | 24 | $1,818 | $70 |
| Short return visit (20+ min) | 31 | $1,729 | $45 |
| Short return visit (20+ min) | 30 | $1,642 | $44 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $1,462 | $77 |
| Muscle electrical test | 18 | $1,429 | $68 |
| Nerve test | 14 | $1,006 | $72 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $730 | $43 |
| Muscle electrical test | 15 | $250 | $17 |
2013: 18 services
| New patient visit (45+ min) | 88 | $10,571 | $120 |
| Short return visit (20+ min) | 127 | $10,480 | $52 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 52 | $6,495 | $97 |
| Long return visit (40+ min) | 54 | $5,522 | $102 |
| Muscle electrical test | 65 | $5,340 | $64 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 36 | $4,097 | $85 |
| Return visit (30+ min) | 46 | $3,732 | $73 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,147 | $195 |
| Nerve test | 22 | $2,090 | $95 |
| New patient visit (30+ min) | 23 | $1,816 | $79 |
| Nerve test | 21 | $1,772 | $84 |
| Nerve test | 13 | $1,759 | $135 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 23 | $1,409 | $50 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $1,204 | $40 |
| Muscle electrical test | 24 | $793 | $27 |
| Short return visit | 20 | $732 | $33 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 13 | $286 | $20 |
| Insertion of needle into vein for collection of blood sample | 16 | $47 | $3 |
Medicaid work
$431 in 2024
Medicaid paid $431 for 13 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 13 | $431 |
| 2024 | 13 | 1 | 12 | $431 |
Drugs they prescribed that Part D paid
$257
Pharmacies billed $257 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
31 generic and 0 brand-name prescriptions · $257 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Meloxicam | 11 | $129 | $12 |
Year by year
| 2024 | 31 | 20 | None | 0% | $257 |
| 2023 | 20 | 14 | None | 0% | $188 |
| 2022 | 22 | 12 | None | 0% | $88 |
| 2021 | 21 | 13 | None | 0% | $509 |
| 2020 | 22 | 15 | 0% (0) | None | $446 |
| 2019 | 21 | 15 | None | None | $487 |
| 2018 | 28 | 20 | None | None | $542 |
| 2017 | 23 | 16 | None | None | $1,009 |
| 2016 | 43 | 17 | None | 26% | $3,189 |
| 2015 | 46 | 27 | None | 26% | $3,161 |
| 2014 | 92 | 41 | 15% (14) | None | $2,718 |
| 2013 | 213 | 95 | 19% (40) | 15% | $9,525 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2016: 1 drug
| Carbamazepine Er | 11 | $1,034 | $94 |
2015: 1 drug
| Lidocaine | 12 | $2,319 | $193 |
2014: 3 drugs
| Lidocaine | 23 | $1,694 | $74 |
| Gabapentin | 20 | $353 | $18 |
| Primidone | 12 | $103 | $9 |
2013: 6 drugs
| Lidocaine | 54 | $3,983 | $74 |
| Gabapentin | 43 | $777 | $18 |
| Voltaren | 16 | $565 | $35 |
| Tramadol | 31 | $478 | $15 |
| Meloxicam | 17 | $136 | $8 |
| Nortriptyline | 16 | $111 | $7 |
Money from drug and device companies
$59 in 2025
| 2025 | 2 | 2 | None | $59 |
| 2024 | 1 | 1 | None | $29 |
| 2021 | 2 | 4 | None | $83 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Intracept | $39 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $20 | 1 payment
|
See all 2 published payments
| Tactile Systems Technology | Meals · 2025-10-29 | Flexitouch Plus | $20 |
| Boston Scientific | Meals · 2025-09-17 | Intracept | $39 |
See earlier years (2024, 2021)
2024: $29
| Boston Scientific | None | $29 | 1 payment
|
2021: $83
| Relievant Medsystems | Intracept | $44 | 2 payments
|
| Carl Zeiss Meditec USA | Artevo 800 | $40 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1528182532
- Licence
- CA C129385, WI 51438California C129385: Current · expires 2028-01-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WI 34993900
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 204R00000X (204R00000X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-03-16
- NPI last updated
- 2024-04-28
- NPI record certified
- 2024-04-28
This is when the NPI record was last certified, not a medical board exam.